Skip to main content
Kent State University Home

Open Access Kent State (OAKS)

  • About
    • About
    • Frequently Asked Questions
    • Rights and Reuse
  • Browse
    • Authors
    • Collections
    • Communities
    • Subjects
  • Login

Treating Neuropathology with the Novel Hormone Irisin

  1. Open Access Kent State
  2. Conferences & Events
  3. Undergraduate Research Symposium
  4. 2020 - Kent State University Undergraduate Symposium on Research, Scholarship and Creative Activity
  5. Biomedical Sciences
  6. Treating Neuropathology with the Novel Hormone Irisin
File
Author(s)
  • Kimberly Bretland Senior, Biology (Molecular and Cellular Biology)
Abstract
Alzheimer’s disease is characterized by neuroinflammation and neural accumulation of pathological tau. One candidate for treatment is a recently discovered hormone irisin, which is a cleaved product from the fibronectin type III domain-containing protein 5 (FNDC5) transmembrane protein. We have preliminary data showing that weekly injections of recombinant irisin decreased neuroinflammation and tau pathology in 4-month old female htau mice that express a mutant, humanized gene associated with late-onset Alzheimer’s disease. In the current study, we determined how changes in treatment frequency and age affected neuropathology, inflammation, and FNDC5 levels in htau mice and their wildtype littermates that lack any form of tau.
Format
Conference Proceeding
Contributor(s)
Faculty Mentor
Christine Dengler-Crish
Modified Abstract

Alzheimer’s disease is characterized by neuroinflammation and neural accumulation of pathological tau. One candidate for treatment is a recently discovered hormone irisin, which is a cleaved product from the fibronectin type III domain-containing protein 5 (FNDC5) transmembrane protein. We have preliminary data showing that weekly injections of recombinant irisin decreased neuroinflammation and tau pathology in 4-month old female htau mice that express a mutant, humanized gene associated with late-onset Alzheimer’s disease. In the current study, we determined how changes in treatment frequency and age affected neuropathology, inflammation, and FNDC5 levels in htau mice and their wildtype littermates that lack any form of tau.

Download full text 1.61MB
  • Facebook
  • Linkedin
  • Twitter
  • Pinterest
  • Email
Open Access Kent State
University Libraries

Street Address

1125 Risman Dr.
Kent, OH 44242

Mailing Address

P.O. Box 5190
Kent, OH 44242-0001

Contact Us

  • oaks [at] kent [dot] edu

Quick Links

  • About
  • Frequently Asked Questions
  • Rights and Reuse

Information

  • Accessibility
  • Annual Security Reports
  • Emergency Information
  • For Our Alumni
  • For the Media
  • Health Services
  • Jobs & Employment
  • May 4th, 50th Commemoration
  • Privacy Statement
  • Website Feedback
Kent State University Home
© 2021 Kent State University All rights reserved.